BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2187704)

  • 1. Muscarinic receptor subtypes in rat pancreatic islets: binding and functional studies.
    Verspohl EJ; Tacke R; Mutschler E; Lambrecht G
    Eur J Pharmacol; 1990 Mar; 178(3):303-11. PubMed ID: 2187704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic receptor subtypes in human and rat colon smooth muscle.
    Gómez A; Martos F; Bellido I; Marquez E; Garcia AJ; Pavia J; Sanchez de la Cuesta F
    Biochem Pharmacol; 1992 Jun; 43(11):2413-9. PubMed ID: 1610405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD; Mash DC
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]N-methylscopolamine binding studies reveal M2 and M3 muscarinic receptor subtypes on cerebellar granule cells in primary culture.
    Alonso R; Didier M; Soubrie P
    J Neurochem; 1990 Jul; 55(1):334-7. PubMed ID: 2355226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes.
    Waelbroeck M; Camus J; Tastenoy M; Feifel R; Mutschler E; Tacke R; Strohmann C; Rafeiner K; Rodrigues de Miranda JF; Lambrecht G
    Br J Pharmacol; 1994 Jun; 112(2):505-14. PubMed ID: 8075869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of thiol groups, calcium, and glucose metabolism on cholinergic-induced insulin release and on methylscopolamine binding to muscarinic receptors in pancreatic islets of the rat.
    Grill V; Fåk K
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):355-60. PubMed ID: 2411095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of muscarinic receptors in dog tracheal smooth muscle cells.
    Yang CM
    J Auton Pharmacol; 1991 Feb; 11(1):51-61. PubMed ID: 2030109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB; Eubanks JH; Creese I
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of glucagon-like peptide-1 secretion by muscarinic agonist in a murine intestinal endocrine cell line.
    Abello J; Ye F; Bosshard A; Bernard C; Cuber JC; Chayvialle JA
    Endocrinology; 1994 May; 134(5):2011-7. PubMed ID: 8156901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine.
    Giraldo E; Micheletti R; Montagna E; Giachetti A; Viganò MA; Ladinsky H; Melchiorre C
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1016-20. PubMed ID: 3252019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
    Waelbroeck M; Tastenoy M; Camus J; Christophe J
    Mol Pharmacol; 1990 Aug; 38(2):267-73. PubMed ID: 2385234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
    Smith TD; Annis SJ; Ehlert FJ; Leslie FM
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
    Cortés R; Probst A; Tobler HJ; Palacios JM
    Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic receptor subtypes on rat pancreatic acini: secretion and binding studies.
    Louie DS; Owyang C
    Am J Physiol; 1986 Aug; 251(2 Pt 1):G275-9. PubMed ID: 2426974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites.
    Delmendo RE; Michel AD; Whiting RL
    Br J Pharmacol; 1989 Feb; 96(2):457-64. PubMed ID: 2924085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic receptors in pancreatic islets of the rat. Demonstration and dependence on long-term glucose environment.
    Grill V; Ostenson CG
    Biochim Biophys Acta; 1983 Mar; 756(2):159-62. PubMed ID: 6338932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic responses of gastric parietal cells.
    Wilkes JM; Kajimura M; Scott DR; Hersey SJ; Sachs G
    J Membr Biol; 1991 Jun; 122(2):97-110. PubMed ID: 1895339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini.
    Korc M; Ackerman MS; Roeske WR
    J Pharmacol Exp Ther; 1987 Jan; 240(1):118-22. PubMed ID: 2433426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and binding studies with muscarinic M2-subtype selective antagonists.
    Lazareno S; Roberts FF
    Br J Pharmacol; 1989 Sep; 98(1):309-17. PubMed ID: 2804551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.